HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Botryosphaeran, [(1 → 3)(1 → 6)-β-D-glucan], induces apoptosis-like death in promastigotes of Leishmania amazonensis, and exerts a leishmanicidal effect on infected macrophages by activating NF-kB and producing pro-inflammatory molecules.

Abstract
Leishmaniasis is an infectious-parasitic disease caused by the protozoan Leishmania spp. The available treatments are based upon expensive drugs bearing adverse side-effects. The search for new therapeutic alternatives that present a more effective action without causing adverse effects to the patient is therefore important. The objective of this study was to evaluate the in vitro effect of botryosphaeran, a (1 → 3)(1 → 6)-β-D-glucan, on the promastigote and intracellular amastigote forms of Leishmania amazonensis. The direct activity of botryosphaeran on promastigote forms was evaluated in vitro and inhibited proliferation, the IC50 7 μg/mL in 48 h was calculated. After 48 h treatment, botryosphaeran induced nitric oxide production (NO), caused mitochondrial membrane hyperpolarization, increased reactive oxygen species (ROS), and accumulation of lipid vesicles in promastigotes, resulting in apoptosis, necrosis and autophagy, and was accompanied by morphological and ultrastructural changes. The range of concentrations used did not alter the viability of peritoneal macrophages from BALB/c mice and erythrocytes of sheep. Botryosphaeran was able to reduce the number of infected macrophages and the number of amastigotes per macrophage at 12.5 μg/mL (50.75% ± 6.48), 25 μg/mL (55.66% ± 3.93) and 50 μg/mL (72.9% ± 6.98), and IC50 9.3 μg/mL (±0.66) for intracellular amastigotes forms. The leishmanicidal effect was due to activation of NF-κB and promoted an increase in pro-inflammatory cytokines (TNF-α and IL-6), iNOS and microbial-derived ROS and NO, in addition to decreasing the levels of SOD. Based upon the data obtained, we infer that botryosphaeran exerted an active leishmanicidal and immunomodulatory effect, acting on promastigotes through autophagic, apoptotic and necrosis processes, and in the intracellular amastigote form, through the action of ROS and NO.
AuthorsAmanda Cristina Machado Carloto, Bruna Taciane da Silva Bortoleti, Ana Carolina Jacob Rodrigues, Taylon Felipe Silva, Fernanda Tomiotto-Pellissier, Danielle Lazarin Bidóia, Manoela Daiele Gonçalves, João Paulo Assolini, Robert F H Dekker, Aneli M Barbosa-Dekker, Idessania Nazareth Costa, Ivete Conchon-Costa, Milena Menegazzo Miranda-Sapla, Wander Rogério Pavanelli
JournalChemico-biological interactions (Chem Biol Interact) Vol. 351 Pg. 109713 (Jan 05 2022) ISSN: 1872-7786 [Electronic] Ireland
PMID34699765 (Publication Type: Journal Article)
CopyrightCopyright © 2021 Elsevier B.V. All rights reserved.
Chemical References
  • Glucans
  • Immunologic Factors
  • Interleukin-6
  • NF-kappa B
  • Trypanocidal Agents
  • Tumor Necrosis Factor-alpha
  • botryosphaeran
  • interleukin-6, mouse
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Superoxide Dismutase
Topics
  • Animals
  • Apoptosis (drug effects)
  • Cell Proliferation (drug effects)
  • Glucans (pharmacology)
  • Immunologic Factors (pharmacology)
  • Interleukin-6 (metabolism)
  • Leishmania (drug effects)
  • Macrophages, Peritoneal (drug effects, microbiology)
  • Male
  • Mice, Inbred BALB C
  • NF-kappa B (metabolism)
  • Necrosis (chemically induced)
  • Nitric Oxide Synthase Type II (metabolism)
  • Oxidative Stress (drug effects)
  • Parasitic Sensitivity Tests
  • Superoxide Dismutase (metabolism)
  • Trypanocidal Agents (pharmacology)
  • Tumor Necrosis Factor-alpha (metabolism)
  • Mice

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: